Polyrizon partners with Clearmind to develop intranasal MEAI formulation

Go back to Polyrizon partners with Clearmind to develop intranasal MEAI formulation
(NASDAQ: CMND) Delayed: 1.67 +0.03 (1.83%)
Previous Close $1.64    52 Week High
Open $1.67    52 Week Low
Day High $1.69    P/E N/A 
Day Low $1.61    EPS
Volume 45,755       

(NASDAQ: PLRZ) Delayed: 14.39 +0.90 (6.67%)
Previous Close $13.49    52 Week High
Open $13.71    52 Week Low
Day High $14.73    P/E N/A 
Day Low $13.40    EPS
Volume 81,295